O
CELG
OrbiMed’s Celgene Corp CELG Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-295,000
| Closed | -$27.8M | – | 138 |
|
|
2019
Q1 | $27.8M | Sell |
295,000
-2,961,700
| -91% | -$279M | 0.43% | 59 |
|
|
2018
Q4 | $209M | Buy |
3,256,700
+792,850
| +32% | +$50.8M | 3.86% | 4 |
|
|
2018
Q3 | $220M | Sell |
2,463,850
-106,800
| -4% | -$9.56M | 2.66% | 8 |
|
|
2018
Q2 | $204M | Sell |
2,570,650
-63,600
| -2% | -$5.05M | 2.44% | 9 |
|
|
2018
Q1 | $235M | Sell |
2,634,250
-428,600
| -14% | -$38.2M | 2.91% | 7 |
|
|
2017
Q4 | $320M | Sell |
3,062,850
-289,127
| -9% | -$30.2M | 4.04% | 4 |
|
|
2017
Q3 | $489M | Sell |
3,351,977
-73,800
| -2% | -$10.8M | 4.67% | 3 |
|
|
2017
Q2 | $445M | Buy |
3,425,777
+293,600
| +9% | +$38.1M | 4.66% | 2 |
|
|
2017
Q1 | $390M | Buy |
3,132,177
+25,400
| +0.8% | +$3.16M | 4.42% | 3 |
|
|
2016
Q4 | $360M | Buy |
3,106,777
+158,200
| +5% | +$18.3M | 4.58% | 3 |
|
|
2016
Q3 | $308M | Buy |
2,948,577
+543,900
| +23% | +$56.9M | 3.51% | 5 |
|
|
2016
Q2 | $237M | Sell |
2,404,677
-1,369,400
| -36% | -$135M | 2.47% | 10 |
|
|
2016
Q1 | $378M | Buy |
3,774,077
+108,627
| +3% | +$10.9M | 3.97% | 8 |
|
|
2015
Q4 | $439M | Buy |
3,665,450
+72,450
| +2% | +$8.68M | 3.98% | 7 |
|
|
2015
Q3 | $389M | Sell |
3,593,000
-233,000
| -6% | -$25.2M | 3.92% | 6 |
|
|
2015
Q2 | $443M | Buy |
3,826,000
+654,000
| +21% | +$75.7M | 3.7% | 6 |
|
|
2015
Q1 | $366M | Sell |
3,172,000
-485,600
| -13% | -$56M | 3.12% | 5 |
|
|
2014
Q4 | $409M | Buy |
3,657,600
+329,600
| +10% | +$36.9M | 3.91% | 4 |
|
|
2014
Q3 | $315M | Buy |
3,328,000
+673,000
| +25% | +$63.8M | 3.29% | 9 |
|
|
2014
Q2 | $228M | Buy |
2,655,000
+1,283,600
| +94% | +$110M | 2.68% | 12 |
|
|
2014
Q1 | $191M | Sell |
1,371,400
-385,700
| -22% | -$53.8M | 2.35% | 12 |
|
|
2013
Q4 | $297M | Buy |
1,757,100
+450,100
| +34% | +$76.1M | 4.36% | 3 |
|
|
2013
Q3 | $201M | Buy |
1,307,000
+70,600
| +6% | +$10.9M | 3.59% | 6 |
|
|
2013
Q2 | $145M | Buy |
+1,236,400
| New | +$145M | 3.07% | 8 |
|